GRI vs MCK · P/E 0.1, $3.5M cap vs P/E 20, rev $403.43B
GRI Bio Inc. (GRI) versus McKesson Corporation (MCK) — a side-by-side from cached financials, not a winner call.
GRI Bio Inc. (GRI) is a biotechnology company listed on US.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
GRI does not have a complete income-statement cache yet.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
GRI currently screens at market cap $3.5M and trailing P/E 0.1. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Not investment advice. Open the GRI and MCK stock pages for the full models.
Not investment advice.